Posts tagged ‘AUA 2011 Conference’
Icarus Consultants will be attending the annual meeting of the American Urological Association (AUA) that starts in Washington DC this weekend.
On Biotech Strategy Blog, Pieter Droppert has written about the independent satellite symposia he will be attending. These are not officially part of the AUA meeting, but associated with it.
One of the symposia is on managing skeletal-related events in patients with prostate cancer. In his blog post, Pieter discusses some of the unanswered questions around this topic such as the impact on Quality of Life (QoL) in patients with bone-metastatic castrate resistant prostate cancer (CRPC).
You can read more about which AUA satellite symposia Pieter will be attending and what information and insight he hopes to obtain from them on Biotech Strategy Blog.
This Friday sees the start of the 2011 annual meeting of the American Urological Association (AUA) in Washington, DC. The meeting runs from May 14-19.
We expect the recent FDA approval of abiraterone acetate (Zytiga®) from Ortho Biotech (JNJ) to be hot news at the meeting as urologists seek to learn more about it’s use.
Icarus Consultants will be in our Nation’s Capital for AUA, so should you be interested in meeting up, please contact us.